Published September, 2016
By Attilio Orazi, Daniel A. Arber, Elaine Sarkin Jaffe, Nancy Lee Harris, Elias Campo, Daniel MD Arber, Daniel Arber, Leticia Quintanilla-Martinez, Dr. Leticia Quintanilla-Martinez, Leticia Quintanilla-Fend, Elias MD Campo and Elaine Jaffe
Publisher: Elsevier (Elsevier - Health Sciences Division)
Rating:
Availability: Available

---

Published September, 2016
By Syed A. Abutalib, Jean M. Connors, Margaret V. Ragni and Jean Marie Connors
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

This book, in Q&A format, addresses a wide range of clinically relevant topics and issues in Nonmalignant Hematology, or "Benign Hematology," with a view to offering a robust, engaging tool that will assist every hematologist and oncologist (pediatric and adult equally) in making decisions during day-to-day practice.

---

Published September, 2016
By Hae Won Kim, A. Gerson Greenburg and A.Gerson Greenburg
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating: 3.00
Availability: Available

Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions.

---

Published September, 2016
By George M. Yousef and Serge Jothy
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

The book provides a brief, easy to read review of commonly employed diagnostic molecular techniques including recently developed "next generation" analytic tools, and offers a system-based run-through of the utility of molecular testing in individual cancer types, as well as reviewing current markers in cancer diagnosis, prognosis, and management.

---

Published August, 2016
By John Bartholomew and Alan Lichtin
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP).The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field's most recent developments.

---

Published August, 2016
By Paul Monagle
Publisher: Springer (Humana Press Inc.)
Rating:
Availability: Available

The haemostatic system is one the most important physiological systems for maintaining health and well being, and thus the investigation of the haemostatic system remains a research priority.

---

Published August, 2016
By Torsten Haferlach, H. Joachim Deeg, David T. Bowen, Steven D. Gore, Michelle M. Le Beau and Charlotte Niemeyer
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating: 1.00
Availability: Available

The diagnosis of myelodysplastic syndromes (MDS), a heterogeneous group of clonal hematopoietic disorders, is being made with increasing frequency over the past decade owing to increased recognition, improved understanding, and an aging population.

---

Published August, 2016
By Nima Rezaei
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field.

---

Published August, 2016
By Sami Malek
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

In this book, the authors focus on crucial aspects of chronic lymphocytic leukemia (CLL) pathogenesis and delineate the known and unknown in CLL to inform readers and to motivate out of the box thinking in future CLL research.

---

Published August, 2016
By Michael E. Williams and Martin Dreyling
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors.

---